Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approachesTheodoros Karantanos, Timothy C. Thompson|Oncogene|2013Cited by 879
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Timothy C. Thompson|Oncotarget|2016Cited by 29
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Melanie Klausner et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
CCRL2 As a Novel Target in Acute Erythroid LeukemiaNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|Blood|2024Cited by 0
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Suman Paul, Nour Sabiha Naji et al.|Research Square|2025Cited by 0